BioCryst Pharmaceuticals
BCRX
#4498
Rank
HK$13.17 B
Marketcap
HK$63.04
Share price
2.07%
Change (1 day)
83.72%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total debt

Total debt on the balance sheet as of December 2024 : HK$6.27 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total debt is HK$6.27 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

BioCryst Pharmaceuticals - Total debt on balance sheet (from 1996 to 2024)

Total debt by year

Year Total debt Change
2024-12-31HK$6.27 B-2.57%
2023-12-31HK$6.44 B11.24%
2022-12-31HK$5.79 B25.24%
2021-12-31HK$4.62 B113.49%
2020-12-31HK$2.16 B228.65%
2019-12-31HK$0.65 B36.18%
2018-12-31HK$0.48 B13.24%
2017-12-31HK$0.42 B2.62%
2016-12-31HK$0.41 B78.11%
2015-12-31HK$0.23 B0.52%
2014-12-31HK$0.23 B0.03%
2013-12-31HK$0.23 B0.04%
2012-12-31HK$0.23 B-0.2%
2011-12-31HK$0.23 B
2000-12-31HK$0.07 M
1997-12-31HK$0.77 M-66.6%
1996-12-31HK$2.32 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
HK$5.32 B-15.15%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$10.42 B 66.07%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$11.63 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$1.78 B-71.51%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$207.24 B 3,202.78%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$29.58 M-99.53%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$165.38 B 2,535.69%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$5.14 B-17.93%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$86.01 M-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA